National Drug Abuse Treatment 

  PROTOCOL NIDA-CTN-0012

Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs

Lawrence Brown, Jr., M.D., M.P.H.
Lead Investigator

Division of Medical Services
Addiction Research and Treatment Corporation
22 Chapel St.
Brooklyn, NY 11201
Lbrown@artcny.org


Substance abuse is associated with a wide spectrum of medical disorders, including infections due to the human immunodeficiency virus (HIV) and the hepatitis C virus (HCV) as well as sexually transmitted infections. Despite the seriousness of this problem, there has not been a systematic investigation of infectious disease services in the substance abuse treatment health care delivery system.  This is a study of policies and services in Community Treatment Programs (CTPs) related to these infections. The study surveys CTP administrators and direct care providers and reviews policies related to clinical guidelines and reimbursement policies through a survey of administrators of state substance abuse agencies or health departments.  In addition to filling the information gap about available services for infectious disease in substance abuse treatment programs, this study will provide a basis for later studies on the efficiency of these services and of health outcomes.

  LATEST RESEARCH AND FINDINGS
Find publications in the Library about Protocol CTN-0012
Researchers: Data from this protocol is available from CTN Public Datashare.

NODES & CTPs SEARCH
LINK
All Nodes and CTPs were asked to participate in this protocol.)
OTHER RESOURCES
NIDA protocol page


Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 3/2007 -- http://ctndisseminationlibrary.org/protocols/ctn0012.htm
info@disseminationlibrary.org